Keynote SessionsOur keynote sessions set the tone for the entire congress, bringing together thought leaders from leading organizations
to share their vision of how technology is transforming the clinical trial landscape. These high-level talks focus on
company-wide transformation and change, exploring how to adopt emerging technologies and embrace innovative trial
models that drive smarter clinical development.
Speakers:
- Johannes Streffer, SVP, Global Clinical Development, Lundbeck
- Sid Jain, SVP, Clinical Development & Data Science, Recursion
- David Carruthers, Vice President BioPharmaceuticals R&D Clinical Operations, AstraZeneca
- Samantha Warden, VP & Global Head Clinical Programming & Business Excellence, GSK
- Liz Nevin, Executive Director R&D IT, E2E R&D, AstraZeneca
- Matthew Bonam, VP, Head of BioPharmaceuticals R&D Digital Patient Health & Innovation, AstraZeneca
The Connected Patient“Putting the patient at the centre of every trial”
This session explores how digital innovation not only broadens access, but also improves patient matching,
optimizes study workflows, and delivers richer insights to drive better outcomes.
- AI-Driven Site and Participant Matching
- Relieving the patient burden
- How are novel technologies enabling decentralized trial design and execution?
- Advanced wearables and sensors for continuous, real-world monitoring of patient behaviour and disease progression
- Overcoming geographic limitations using virtual site technology
- Digital platforms for patient co-design to shape trial protocols and improve experience
- How can digital interfaces and support tools enable flexible patient participation?
- Generating real-time safety alerts triggered by biometric data
Speakers:
- Nadir Ammour, Global Lead Clinical Innovation and External Partnerships, Sanofi
- Laszlo Vasko, Senior Director, Therapeutic Enabling Innovation, R&D IT, J&J Innovative Medicine
- Jan Seidel, Senior Principal Therapeutic Area & Methodology (TAM) Statistician, Boehringer Ingelheim
Next Generation Clinical Trials“Smarter trials, faster insights”
This session explores the tools and approaches that could reshape the entire clinical development lifecycle.
- Digital twins to simulate trial scenarios and optimize design
- Agentic and autonomous workflows that monitor data and trigger protocol adjustments without manual intervention
- Technology to support adaptive clinical trials
- AI-driven patient stratification
- Generation and application of synthetic patient data
Speakers:
- Manish Khatri, Director, Clinical Science Data & AI Lead – Oncology Portfolio | Global Clinical Development, Novartis
- Gerry Grove, Senior Director, Study and Digital Solutions, AstraZeneca
- Davide Carluccio, Principal Global Clinical Operations Manager, Almirall
- Vesela Aleksandrova, Clinical Oversight and Strategy Director, Shionogi
- Carl Johan Nordmark, Executive Director, Head of IT – Development and Late Therapeutic Areas, AstraZeneca
Data Strategy“Building the data backbone for connected trials”
This session will cover how to build a future-ready data foundation for smarter clinical trials.
- Data mapping and harmonization to align diverse sources into a single usable format
- Real-time data sharing, collaboration, and analytics across partners, trials, and countries
- Building a foundation for advanced analytics, AI, and regulatory readiness to enable faster, smarter decision-making
- Connecting global standards
- Unified operational data to streamline trial oversight and performance monitoring
- Scalable cloud or hybrid infrastructure to support high-volume, decentralized, and global trials
- Robust data governance, quality, and compliance frameworks
Speakers:
- Alastair Clewlow, Senior Director, Clinical Data Management, Statistical Programming & Digital Solutions, Lundbeck
- Luca Finelli, VP, Global Head of Data Science, Analytics and Imaging (Personalized Healthcare), Roche
- Manish Khatri, Director, Clinical Science Data & AI Lead – Oncology Portfolio | Global Clinical Development, Novartis
- Volodymyr Anisimov, Data Science Director, Amgen
- Manesh Patel, Biostatistics Capability Development, GSK
- Clara Cali Mella, Senior Analytics and Insights Manager, Bayer Pharma
- Chrissie Fletcher, VP Respiratory, Immunology and Inflammation Statistics, Biostatistics, GSK
- Nicola Götz, Global Biostatistics & Data Sciences, Boehringer Ingelheim
- Isabela Niculae, Head Clinical Innovation and Digital Solutions / Global Clinical Operations, UCB
- Hassan Khalid, Director – Senior Engineer, Machine Learning and Data Science, AstraZeneca
Digital Biomarkers“Sharpening endpoints, boosting safety”
This session will explore the latest innovations, real-world applications, and strategies for integrating
digital biomarkers into clinical trial design.
- Capturing real-time patient insights without disrupting daily life to enhance trial efficiency and compliance
- Validating new digital biomarkers
- How can digital signals be used to identify disease markers sooner?
- Integration of digital biomarkers with traditional data sources
- How to utilise a range of biomarker types to support personalised medicine
Speakers:
- Christian Gossens, Digital Biomarkers Chapter Lead, Roche
- Teske Valk, Senior International Medical Manager, Novo Nordisk
- Davide Carluccio, Principal Global Clinical Operations Manager, Almirall
Strategic Application of Robotics and Automation Tools
“Precision at scale”
This session will review how robotic and automation tools are enabling trials to be run more efficiently,
deliver higher-quality data, and accelerate the path to insights.
- Sample handling and processing for improved efficiency and accuracy in clinical workflows
- Applying automation tools to simplify data entry and validation
- Utilizing digital solutions to accelerate the creation, management, and submission of regulatory documents
- Integrating virtual assistants to support both site staff and patients
- Automating the bioanalysis of samples
Speakers:
- Jonathan Crowther, Head of Operational Design Centre, Merck Healthcare
